CANC ETF

CANC ETF
$42.11
See how much of CANC you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

RVMD is CANC's largest holding at 5.34% of the fund as of Sep 2, 2026. CANC is Tema Oncology ETF.

Showing top 50 of 59 holdings · as of Sep 2, 2026
CANC holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
RVMD
Revolution Medicines IncHealth Care · Biotechnology
5.34%
5.3%54,887$11.48MHealth CareBiotechnology
2
COGT
Cogent Biosciences IncHealth Care · Biotechnology
4.87%
10.2%303,132$10.48MHealth CareBiotechnology
Sector and industry · Pro
3
MRK
Merck & Company Inc
4.62%
14.8%65,538$9.94M
4
LLY
Eli Lilly & Co.
4.37%
19.2%8,097$9.39M
5
NVS
Novartis Ag -
3.97%
23.2%52,786$8.53M
6
BMY
Bristol-Myers Squibb Co.
3.57%
26.7%113,617$7.69M
7
ABBV
AbbVie Inc.
3.35%
30.1%27,506$7.20M
8
ONC
Beigene, Ltd. Adr
3.16%
33.3%18,783$6.80M
9
JNJ
Johnson & Johnson -
3.16%
36.4%24,705$6.80M
10
IMNM
Immunome Inc
2.95%
39.4%232,377$6.35M
11
RHHBY
Roche Holding Ag (Adr)
2.95%
42.3%117,767$6.34M
12Genmab A/s ADR
2.94%
45.3%184,482$6.31M
13
HALO
Halozyme Therapeutics Inc
2.94%
48.2%57,674$6.32M
14
EXEL
Exelixis Inc
2.78%
51.0%102,082$5.97M
15
CGON
Cg Oncology Inc
2.71%
53.7%78,021$5.82M
16
IDYA
Ideaya Biosciences Inc
2.67%
56.4%143,144$5.75M
17
ELVN
Enliven Therapeutics Inc
2.66%
59.0%97,054$5.73M
18
BBIO
Bridgebio Pharma Inc_None_0
2.59%
61.6%72,853$5.57M
19
AMGN
Amgen Inc.
2.09%
63.7%10,157$4.50M
20
LEGN
Legend Biotech Corp-adr
2.03%
65.7%199,149$4.36M
21
ERAS
Erasca Inc.
2.02%
67.7%265,462$4.35M
22
ZLAB
Zai Lab Ltd
2.00%
69.7%162,268$4.30M
23AstraZeneca PLC
1.96%
71.7%26,142$4.22M
24
CELC
Celcuity Inc
1.93%
73.6%43,098$4.15M
25
RLAY
Relay Therapeutics Inc
1.90%
75.5%221,256$4.10M
26Zymeworks Inc.
1.61%
77.1%111,287$3.46M
27
IOVA
Iovance Biotherapeutics Inc
1.53%
78.7%381,012$3.28M
28
NUVB
Nuvation Bio Inc
1.35%
80.0%419,197$2.91M
29
URGN
Urogen Pharma Ltd Com Ils0.01
1.27%
81.3%61,654$2.74M
30
RCUS
Arcus Biosciences Inc
1.22%
82.5%87,601$2.61M
31
KURA
Kura Oncology Inc
1.05%
83.6%172,438$2.26M
32
GILD
Gilead Sciences
1.03%
84.6%14,736$2.20M
33
SMMT
Summit Therapeutics
1.02%
85.6%150,956$2.20M
34
TYRA
Tyra Biosciences Inc
1.00%
86.6%85,845$2.16M
35
CRVS
Corvus Pharmaceuticals Inc
0.95%
87.6%143,598$2.04M
36
NTRA
Natera Inc
0.93%
88.5%6,120$1.99M
37
ANAB
Anaptysbio Inc
0.86%
89.4%32,945$1.84M
38
REPL
Replimune Group Inc
0.81%
90.2%109,079$1.74M
39
IMTX
Immatics Nv
0.80%
91.0%180,721$1.72M
40Immunocore Holdings Ltd Adr
0.79%
91.8%45,176$1.69M
41
CGEM
Cullinan Therapeutics Inc
0.69%
92.4%66,187$1.48M
42
ORIC
ORIC Pharmaceuticals, Inc.
0.68%
93.1%111,490$1.46M
43
GH
Guardant Health, Inc
0.67%
93.8%8,824$1.44M
44
FXFXX
First Am Treas Obli-X
0.61%
94.4%1,319,262$1.32M
45
TNGX
Tango Therapeutics Inc.
0.58%
95.0%56,146$1.25M
46
CADL
Candel Therapeutics Inc.
0.53%
95.5%86,865$1.15M
47
SNDX
Syndax Pharmaceuticals Inc
0.53%
96.0%55,298$1.15M
48
JANX
Janux Therapeutics Inc
0.50%
96.5%54,283$1.07M
49
CTMX
Cytomx Therapeutics Inc
0.42%
97.0%242,819$903.3K
50
OLMA
Olema Pharmaceuticals Inc
0.42%
97.4%84,045$910.2K
More holdings · Pro
Not reported for this fund: share changes.
FundXLS Pro
See the other 9 holdings of CANC
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

CANC ETF All Holdings

CANC holdings total 58 positions. The top 10 holdings account for 39.4% of the fund, led by Revolution Medicines Inc at 5.3%, Cogent Biosciences Inc at 4.9%, Merck & Company Inc at 4.6%.

CANC portfolio concentration is moderate, with the top 10 representing 39.4% of total assets. The largest sector exposure is Health Care at 90.1%.

CANC sectors provide a detailed breakdown. CANC overlap shows how holdings compare to other funds in your portfolio.

CANC ETF Holdings

59 of 58 holdings

  • 1

    Revolution Medicines Inc

    RVMDHealth Care
    5.34%
  • 2

    Cogent Biosciences Inc

    COGTHealth Care
    4.87%
  • 3

    Merck & Company Inc

    MRKHealth Care
    4.62%
  • 4

    Eli Lilly & Co.

    LLYHealth Care
    4.37%
  • 5

    Novartis Ag - Common

    NOVN:SMUnknown
    3.97%
  • 6

    Bristol-Myers Squibb Co.

    BMYHealth Care
    3.57%
  • 7

    Abbvie Inc.

    ABBVHealth Care
    3.35%
  • 8

    Beigene, Ltd. Adr

    BGNEHealth Care
    3.16%
  • 9

    Johnson & Johnson - Common

    JNJHealth Care
    3.16%
  • 10

    Immunome Inc

    IMNMHealth Care
    2.95%
  • 11

    Roche Holding Ag (Adr)

    RHHBY:SMUnknown
    2.95%
  • 12

    Genmab A/s ADR

    GMAB:COHealth Care
    2.94%
  • 13

    Halozyme Therapeutics Inc

    HALOHealth Care
    2.94%
  • 14

    Exelixis Inc

    EXELHealth Care
    2.78%
  • 15

    Cg Oncology Inc

    CGONHealth Care
    2.71%
  • 16

    Ideaya Biosciences Inc

    IDYAHealth Care
    2.67%
  • 17

    Enliven Therapeutics Inc

    ELVNHealth Care
    2.66%
  • 18

    Bridgebio Pharma Inc_None_0

    BBIOHealth Care
    2.59%
  • 19

    Amgen Inc.

    AMGNHealth Care
    2.09%
  • 20

    LEGEND BIOTECH CORP-ADR

    LEGNHealth Care
    2.03%
  • 21

    Erasca Inc.

    ERASHealth Care
    2.02%
  • 22

    Zai Lab Ltd

    ZLABHealth Care
    2.00%
  • 23

    AstraZeneca PLC

    AZN:LNUnknown
    1.96%
  • 24

    Celcuity Inc Com

    CELCHealth Care
    1.93%
  • 25

    Relay Therapeutics Inc

    RLAYHealth Care
    1.90%
  • 26

    Zymeworks Inc. Common Stock

    ZYME:CAHealth Care
    1.61%
  • 27

    Iovance Biotherapeutics Inc

    IOVAHealth Care
    1.53%
  • 28

    Nuvation Bio Inc

    NUVBHealth Care
    1.35%
  • 29

    Urogen Pharma Ltd Com Ils0.01

    URGNHealth Care
    1.27%
  • 30

    Arcus Biosciences Inc

    RCUSHealth Care
    1.22%
  • 31

    Kura Oncology Inc

    KURAHealth Care
    1.05%
  • 32

    Gilead Sciences

    GILDHealth Care
    1.03%
  • 33

    Summit Therapeutics

    SMMTHealth Care
    1.02%
  • 34

    Tyra Biosciences Inc

    TYRAHealth Care
    1.00%
  • 35

    Corvus Pharmaceuticals Inc

    CRVSHealth Care
    0.95%
  • 36

    Natera Inc

    NTRAHealth Care
    0.93%
  • 37

    Anaptysbio Inc

    ANABHealth Care
    0.86%
  • 38

    Replimune Group Inc Com

    REPLHealth Care
    0.81%
  • 39

    Immatics Nv

    4A3:BEHealth Care
    0.80%
  • 40

    Immunocore Holdings Ltd Adr

    IMCR:LNHealth Care
    0.79%
  • 41

    Cullinan Therapeutics Inc

    CGEMHealth Care
    0.69%
  • 42

    ORIC Pharmaceuticals, Inc.

    ORICHealth Care
    0.68%
  • 43

    Guardant Health, Inc

    GHHealth Care
    0.67%
  • 44

    First Am Treas Obli-X

    FXFXXFinancials
    0.61%
  • 45

    Tango Therapeutics Inc.

    TNGXHealth Care
    0.58%
  • 46

    Candel Therapeutics Inc.

    CADLHealth Care
    0.53%
  • 47

    Syndax Pharmaceuticals Inc

    SNDXHealth Care
    0.53%
  • 48

    Janux Therapeutics Inc

    JANXHealth Care
    0.50%
  • 49

    Cytomx Therapeutics Inc

    CTMXHealth Care
    0.42%
  • 50

    Olema Pharmaceuticals Inc

    OLMAHealth Care
    0.42%
  • 51

    Bicara Therapeutics, Inc.

    BCAXHealth Care
    0.41%
  • 52

    BRIDGEBIO ONCOLOGY THERAPEUTICS IN

    BBOTUnknown
    0.41%
  • 53

    First Tracks Biotherapeutics, Inc.

    TRAXUnknown
    0.41%
  • 54

    Inhibrx Biosciences Inc

    INBXHealth Care
    0.41%
  • 55

    Arvinas Inc

    ARVNHealth Care
    0.40%
  • 56

    Moderna therapeutics

    MRNAHealth Care
    0.37%
  • 57

    ARRIVENT BIOPHARMA INC

    AVBPHealth Care
    0.31%
  • 58

    Amani Gold Ltd

    ANL:AUUnknown
    0.30%
  • 59

    Autolus Therapeutics Ltd. Adr

    AUTL:LNHealth Care
    0.28%